Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Vaccines|June 27, 2024
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in AustraliaHolly Wang, Lisa Grech, Jennifer Wong, et al.Vaccines|February 28, 2023
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief ModelTammie Choi, Bryan Chan, Lisa Grech, et al.Cancer Medicine|October 11, 2023
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trialAlberto Hernando-Calvo, Eoghan Malone, Daphne Day, et al.JNCI Cancer Spectrum|April 28, 2020
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic IndexDaphne Day, Christina Guo, Yada Kanjanapan, et al.Contemporary Clinical Trials|August 12, 2022
The Sleep, Cancer and Rest (SleepCaRe) Trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapyJordan Maccora, Sheila N Garland, Maria Ftanou, et al.Breast (Edinburgh, Scotland)|December 19, 2024
Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective studyBelinda Sassé, Sammy Shaya, Jessica Nimmo, et al.Cancer Chemotherapy and Pharmacology|October 8, 2025
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation resultsJayesh Desai, Sanjeev Deva, Bo Gao, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 24, 2026
Management of bone health in cancer survivorship: a systematic review of clinical guidelinesVictor Ki Chung Li, Stirling Cosgrove, Katelyn Collins, et al.Journal for Immunotherapy of Cancer|February 22, 2023
SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancerJun Zhao, Xinmin Yu, Dingzhi Huang, et al.Vaccines|September 23, 2022
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ CancersNathan Bain, Mike Nguyen, Lisa Grech, et al.Pageof 4